** Shares of Emyria Ltd EMD.AX rise 32% to A$0.033, their highest since May 22
** The early-stage drug developer announces multi-year agreement with Medibank MPL.AX wherein the latter's customers can access EMD's s Empax PTSD care program
** EMD also raises A$4 million ($2.59 million) at A$0.024, a discount of 4% to the stock's last close
** Says proceeds will be used for programs under the Medibank agreement among others
** Stock set for best day since March 7, if gains hold
** Stock sees busiest session in over two years, as 12 mln shares change hands, 18.1x the 30-day average of 663,166
** MPL up 1.2% to A$4.96 for the session
** EMD down 2.9% YTD, including moves in current session
($1 = 1.5423 Australian dollars)
(Reporting by Jasmeen Ara Shaikh in Bengaluru)
((JasmeenAraIslam.Shaikh@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。